Results 1 - 7 of 7 for subject:"Zymogenetics"
Sorted by Date || Sort by Relevance

February 23, 2009

Biotech, Patents, vaccines Luke Timmerman wrote: One of the world’s best-selling vaccines, Merck’s Gardasil, is quietly producing some serious money for an unexpected benefactor—the University of Washington. Thanks to some hard-fought patent litigation from the 1990s that ended up ...
Xconomy [ Feed - Focus - Exclude ] by Luke Timmerman at 3:00 AM | 3 Citations

February 05, 2009

Biotech, Roundup, Life Sciences Luke Timmerman wrote: Medical devices captured more than its usual mindshare in the Seattle life sciences scene this week, with news of a substantial venture deal and a new product that appears to be catching on in the marketplace. —Pathway Medical Technologies,...
Xconomy [ Feed - Focus - Exclude ] by Luke Timmerman at 1:47 AM | 1 Citations

January 28, 2009

intellectual property, Software, Lists Gregory T. Huang wrote: [Updated Jan. 28, with information on Intellectual Ventures' patents (see below)] If its volume of new patents is any indication, Microsoft is going to be just fine. The Redmond, WA, software firm blew away the rest of Washington state i...
Xconomy [ Feed - Focus - Exclude ] by Gregory T. Huang at 1:03 PM | 1 Citations
Biotech, Autoimmune, diabetes Luke Timmerman wrote: Diabetics can’t just quit taking insulin when the economy takes a nosedive. So if you’re the world’s largest producer of insulin for a chronic, and growing, medical condition, your outlook on life isn’t that bad right now. T...
Xconomy [ Feed - Focus - Exclude ] by Luke Timmerman at 3:00 AM | 2 Citations

January 05, 2009

Biotech, people, Hepatitis C Luke Timmerman wrote: ZymoGenetics is enduring one of the ugliest stretches in its 28-year history. Now the Seattle-based biotech company is hoping that Doug Williams, an executive who lived through both the darkest days and finest moments at Immunex in the 1990s, will b...
Xconomy [ Feed - Focus - Exclude ] by Luke Timmerman at 3:00 AM | 4 Citations

December 24, 2008

Biotech, Drugs, Life Sciences Luke Timmerman wrote: Some of the stories Lynn Rose told me the other week made me laugh out loud, and want to cry in mercy. One story was about the academic researcher who ran a single experiment in an animal species that panned out. This scientist, who shall remain na...
Xconomy [ Feed - Focus - Exclude ] by Luke Timmerman at 3:00 AM | 1 Citations

December 16, 2008

Biotech, people, startups Luke Timmerman wrote: It’s cold outside, so I was a little bummed there was no actual fire at an event last night billed as a “fireside chat.” This get-together actually took some time to warm up (pun intended). But once it got rolling, three of the most e...
Xconomy [ Feed - Focus - Exclude ] by Luke Timmerman at 12:10 PM | 4 Citations
Subscribe to this Search
Get this search in RSS

Add to My Yahoo!
Add to Google
Add to My AOL
Subscribe with Bloglines
Subscribe in NewsGator Online

Mobile
Subscribe on your mobile